Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder

Intravesical injections of BTX-A is an effective therapy in refractory idiopathic OAB over the period of 9 months leading to significant improvement of quality of life in many aspects.